Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Response To Carotid Endarterectomy Audit
Joe Korner, Director of Communications at The Stroke Association said: "This audit shows that there is still a long way to go to make sure people get urgent preventative treatment that could prevent a catastrophic stroke.

National Jewish Health And Ceragenix Announce Compound Shows Promise For Treating Potentially Lethal Viral Infections
Ceragenix Pharmaceuticals, Inc.("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, announced that researchers at National Jewish Health, led by Dr. Donald Y. Leung and Dr. Michael Howell, in collaboration with Dr. Paul B. Savage of Brigham Young University, have demonstrated in a series of in vitro experiments and preclinical animal testing that an investigational drug compound known as CSA-13 shows promise as a potential therapy to treat viral infections from the vaccinia virus. The research appears ahead of print in an advanced online publication of the Journal of Investigate Dermatology, the official journal of the Society for Investigative Dermatology. This work was funded by the National Institute of Allergy and Infectious Diseases Atopic Dermatitis Vaccinia Network.
News of the day
A National Autistic Society (NAS) Response To The National Audit Office (NAO) Report On Adults With Autism
Mark Lever, NAS chief executive said; "In the current economic climate the Government cannot possibly ignore the huge cost savings and benefits, identified by their own auditing body, of providing adults with autism with the right support at the right time. Neither the Government, people with autism nor the taxpayer are getting value for money from existing autism services and support, leaving those affected by the condition feeling isolated, ignored and often at breaking point. This is simply unacceptable.
Nutrition

U.S. Senate Passes Historic Legislation To End Big Tobacco's Unfettered Access To America's Youth

"Today is an historic day for public health, as the U.S. Senate passed legislation by a bipartisan 79-17 vote that will finally put an end to Big Tobacco"s despicable marketing practices that are designed to addict children to its deadly products. Senate passage of the "Family Smoking Prevention and Tobacco Control Act" (S. 982) has the potential to reduce the scourge of tobacco products, which kill more than 400,000 Americans every year. "This critical bill, which has been in the works for more than a decade, would finally grant the U.S. Food and Drug Administration (FDA) authority to regulate the manufacturing, marketing, and sale of tobacco products. "Tobacco is virtually the only consumable product not regulated in the U.S. and the tobacco industry exploits this undeserved free pass by spending nearly $40 million every day aggressively marketing its products, especially to children, with enticing candy- and fruit-flavored cigarettes. The legislation would stop the marketing of tobacco products to children, require tobacco companies to list the poisons in their products and mandate larger and more effective warning labels on tobacco product packaging. "The American Cancer Society Cancer Action Network (ACS CAN), the advocacy affiliate of the American Cancer Society, together with more than 1,000 public health, medical, children"s, and faith-based organizations, supports this long overdue legislation and applauds its passage. ACS CAN commends Senators Harry Reid (D-NV), Christopher Dodd (D-CT) and Richard Durbin (D-IL) for their determination to get this legislation to the President to be signed into law this year, and Senator Edward Kennedy (D-MA) for his leadership on this legislation and his long-time record of championing public health issues. "Every day, 3,500 children pick up their first cigarette and 1,000 become addicted smokers. Regulating the tobacco industry could help break the cycle of addiction to tobacco in our country." ACS CAN is the nonprofit, nonpartisan advocacy affiliate organization of the American Cancer Society, dedicated to eliminating cancer as a major health problem. ACS CAN works to encourage lawmakers, candidates and government officials to support laws and policies that will make cancer a top national priority. ACS CAN gives ordinary people extraordinary power to fight cancer. For more information, visit http://www.acscan.org. ACS CAN


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009